PB Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2001) 25: 174-177. doi: 10.1192/pb.25.5.174
© 2001 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prettyman, R.
Right arrow Articles by Jari, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Prettyman, R.
Right arrow Articles by Jari, J.
Psychiatric Bulletin (2001) 25: 174-177
© 2001 The Royal College of Psychiatrists

Use of a prescribing protocol in routine clinical practice

experience following the introduction of donepezil

Richard Prettyman, Senior Lecturer and Jaiker Jari, Consultant

University of Leicester, Division of Psychiatry for the Elderly, the Bennion Centre, Glenfield General Hospital, Groby Road, Leicester LE3 9DZ

1 The protocol currently followed in Leicestershire is a modified version of the 1997 protocol but the principal components are essentially the same.

AIMS AND METHOD

Following the introduction of donepezil into clinical practice a protocol for prescribing it was developed in Leicestershire. A prospective clinical audit was undertaken to monitor compliance with the protocol, which also provided an opportunity to evaluate the outcome of therapy in routine clinical practice.

RESULTS

Overall there was close adherence to the protocol by the clinicians and clinical factors, as well as organisational and resource-related factors, were important in determining who received treatment. The principal outcome measures (Mini-Mental State Examination, Barthel ADL Index and Clinical Dementia Rating Scale) did not demonstrate any significant treatment effect.

CLINICAL IMPLICATIONS

This study demonstrates the feasibility and acceptability of using a protocol-based approach to manage the introduction of new drug treatments in psychiatry.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2001 The Royal College of Psychiatrists.